Entia Biosciences, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by ANDRES DEVIN D., was filed 12 Nov 2014.
Entia Biosciences, Inc.: what insiders have been doing
Every trade that managers of Entia Biosciences, Inc. disclose to SEC (Form 4) is tracked on this page. Entia Biosciences, Inc. has had no insider filing for more than a year; the last one goes back to 16 February 2017.
The full history, which starts in 2008, counts 8 purchases against no sales.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Since the insiders bought
- -73.5%Entry 0.34 · Close at T+365 0.09
- -73.5%Entry 0.34 · Close at T+365 0.09
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2016FY ended December 2016 · cache
- 1,861,170 shares@ US$0.175100.0% of flowCommon StockSEC:0001185185-17-000392:0
- 600,000 shares0Common StockSEC:0001185185-17-000392:1
- 200,000 shares0Common StockSEC:0001185185-17-000392:2
- 300,000 shares0Common StockSEC:0001185185-17-000392:3
- 250,000 shares0Common StockSEC:0001185185-17-000392:4
- 250,000 shares0Common StockSEC:0001185185-17-000386:0
- 300,000 shares0Common StockSEC:0001185185-17-000386:1
- 250,000 shares0Common StockSEC:0001185185-17-000386:2
- 200,000 shares0Common StockSEC:0001185185-17-000390:0
- 250,000 shares0Common StockSEC:0001185185-17-000390:1
- 300,000 shares0Common StockSEC:0001185185-17-000388:0
- 300,000 shares0Common StockSEC:0001185185-17-000388:1
- 250,000 shares0Common StockSEC:0001185185-17-000388:2
- 1,025,462 shares@ US$0.01Common StockSEC:0001553350-15-001334:0
- 2,050,923 shares@ US$0.01Common StockSEC:0001553350-15-001333:0
- 200,000 shares@ US$0.20Common StockSEC:0001185185-15-001032:0
- 550,000 shares@ US$0.20Common StockSEC:0001185185-15-001011:0
- 600,000 shares@ US$0.20Common StockSEC:0001185185-15-001013:0
- 429,640 shares@ US$0.30COMMON STOCKSEC:0001469709-14-000469:0Canonical exit: 24 Dec 2014 (T+90)
- 2,162,980 shares@ US$0.30COMMON STOCKSEC:0001469709-14-000467:0Canonical exit: 24 Dec 2014 (T+90)
- 52,089 shares@ US$0.38COMMON STOCKSEC:0001469709-13-000718:0Canonical exit: 17 Mar 2014 (T+90)
- 62,505 shares@ US$0.38COMMON STOCKSEC:0001469709-13-000719:0Canonical exit: 17 Mar 2014 (T+90)
- 131,579 shares@ US$0.38COMMON STOCKSEC:0001469709-13-000433:0Canonical exit: 10 Oct 2013 (T+90)
- 131,579 shares@ US$0.38Common StockSEC:0001469709-13-000376:0Canonical exit: 9 Sept 2013 (T+90)
- 173,625 shares@ US$0.036Common StockSEC:0001469709-11-000250:0
25 of 31 declarations
About Entia Biosciences, Inc.
Entia Biosciences, Inc. is a biotechnology company focused on developing health solutions. It aims to enhance quality of life through innovative products.
